Two-dimensional (2D) gel electrophoresis was carried out with
crude cortical membrane proteins to which 2D gel markers were added
(Bio-Rad, Cambridge, MA). For the first-dimension isoelectric focusing,
Immobiline Dry Strips (pH 3–10 nonlinear, Pharmacia LKB Biotechnology,
Piscataway, NJ) were used. Strips were rehydrated in 8 M urea, 1%
octyl-β-d-glucoside, 0.52% Pharmalyte 3–10 (Pharmacia),
13 mM dithiothreitol (DTT), and 0.01% bromophenol blue. Crude cortex
membranes were pelleted at 12,000 rpm for 20 minutes (model 5402;
Eppendorf, Westbury, NY), and washed once with 10 mM HEPES, pH 7.2. The
pellet was solubilized in 9 M urea, 4%
octyl-β-d-glucoside, 2% Pharmalyte 3–10, 65 mM DTT, and
0.01% bromophenol blue. Isoelectric focusing was carried out according
to the manufacturer’s instructions using a Pharmacia LKB Multiphor II
apparatus.
Once focused, isoelectric strips were equilibrated with 100 mM Tris, pH
6.8, 6 M urea, 30% glycerol, 3.5 mM sodium dodecyl sulfate (SDS), and
52 mM DTT, and subsequently with 100 mM Tris, pH 6.8, 6 M urea, 30%
glycerol, 3.5 mM SDS, 0.01% bromophenol blue, and 20 mM iodoacetamide.
A second-dimension gel was run using ExcelGel SDS 12% to 14%
acrylamide (Pharmacia LKB Biotechnology) according to the
manufacturer’s instructions. Protein spots were visualized either by
Coomassie blue or silver staining.
Coomassie blue–stained proteins were given numbers and cut from the
gel using a surgical blade. Pooled proteins were digested in the gel
pieces according to Rosenfeld et al.
16 using 0.2 mg
trypsin per sample for 16 hours at 37°C. Peptides were extracted from
the gel pieces and separated using reversed-phase high-performance
liquid chromatography (HPLC) using a 10% to 70% linear gradient of
buffer A (0.08% TFA) and buffer B (80% acetonitrile, 0.016% TFA) and
a 5-μm C
18 250 × 2-mm column (Phenomenex,
Torrance, CA). Sequencing was done using a Procise 492 protein
sequencer (Applied Biosystems, Foster City, CA).
For single dimension SDS-polyacrylamide gel electrophoresis (PAGE),
15% or 17.5% acrylamide gels were run in a Mini-PROTEAN II cell
(Bio-Rad). Proteins were solubilized without boiling in sample buffer
containing 15 mM Tris, pH 6.8, 20% glycerol, 2% SDS, 5%β
-mercaptoethanol, and 0.01% bromophenol blue. Proteins in the gels
were visualized by silver staining.
For immunoblotting, proteins were transferred electrophoretically in a
Mini-PROTEAN Trans-Blot cell (Bio-Rad) onto Hybond-C pure
nitrocellulose membranes (Amersham Life Science, Arlington Heights,
IL). Blots were stained with 0.1% Ponceau S/1% acetic acid to
visualize and record the positions of lens proteins and molecular
weight markers. After washing in milliQ water, the blots were blocked
overnight at 4°C in 5% nonfat milk powder in TBS. Galectin-3 was
detected with a commercially available monoclonal anti–galectin-3
antibody (Affinity Bioreagents, Deerfield, IL)
17 at a
dilution of 1:200 in TBS containing 1% BSA. MP20 was detected with a
1:1000 dilution of a carboxyl tail peptide–specific antibody that was
kindly donated by Charles Louis, University of Minnesota, St.
Paul.
18 Bound antibodies were detected with alkaline
phosphatase–conjugated secondary antibodies at 1:1000 dilution
according to the manufacturer’s instructions (Immun Star kit;
Bio-Rad), or with biotinylated secondary antibodies at 1:1000 and
streptavidin–horseradish peroxidase at 1:1000 according to the
manufacturer’s instructuctions (ECL; Amersham Life Science).